These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23850849)

  • 41. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
    Leger K; Slone T; Lemler M; Leonard D; Cochran C; Bowman WP; Bashore L; Winick N
    Pediatr Blood Cancer; 2015 Jan; 62(1):123-7. PubMed ID: 25176022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low anthracyclines doses-induced cardiotoxicity in acute lymphoblastic leukemia long-term female survivors.
    Amigoni M; Giannattasio C; Fraschini D; Galbiati M; Capra AC; Madotto F; Cesana F; Jankovic M; Masera G; Mancia G
    Pediatr Blood Cancer; 2010 Dec; 55(7):1343-7. PubMed ID: 20589666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support.
    Lok SI; Winkens B; Goldschmeding R; van Geffen AJ; Nous FM; van Kuik J; van der Weide P; Klöpping C; Kirkels JH; Lahpor JR; Doevendans PA; de Jonge N; de Weger RA
    Eur J Heart Fail; 2012 Nov; 14(11):1249-56. PubMed ID: 22843564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Appraising cardiotoxicity associated with liposomal doxorubicin by means of tissue Doppler echocardiography end-points: rationale and design of the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study.
    Lotrionte M; Palazzoni G; Natali R; Comerci G; Abbate A; Di Persio S; Biondi-Zoccai GG
    Int J Cardiol; 2009 Jun; 135(1):72-7. PubMed ID: 18572266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New insight into the intraventricular pressure gradient as a sensitive indicator of diastolic cardiac dysfunction in patients with childhood cancer after anthracycline therapy.
    Shigemitsu S; Takahashi K; Yazaki K; Kobayashi M; Yamada M; Akimoto K; Tamaichi H; Fujimura J; Saito M; Nii M; Itatani K; Shimizu T
    Heart Vessels; 2019 Jun; 34(6):992-1001. PubMed ID: 30673819
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac functions by myocardial performance index and QT dispersion in survivors of childhood lymphoblastic leukaemia.
    Gulen H; Kazanci E; Mese T; Uzunkaya D; Erbay A; Tavli V; Vergin C
    Minerva Pediatr; 2007 Apr; 59(2):107-13. PubMed ID: 17404560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is there a potential role for serum cardiac troponin I as a marker for myocardial dysfunction in pediatric patients receiving anthracycline-based therapy? A pilot study.
    Mathew P; Suarez W; Kip K; Bayar E; Jasty R; Matloub Y; Raisch D
    Cancer Invest; 2001; 19(4):352-9. PubMed ID: 11405175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Evaluation of late cardiac toxicity of anthracycline in childhood].
    Butera G; Piciacchia D; Chessa M; Condoluci C; Tornesello A; Delogu AB; Mastrangelo S; Cipriani A
    Minerva Pediatr; 1998 Apr; 50(4):111-9. PubMed ID: 9808963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of GSTM1 null variant with anthracycline-related cardiomyopathy after childhood cancer-A Children's Oncology Group ALTE03N1 report.
    Singh P; Wang X; Hageman L; Chen Y; Magdy T; Landier W; Ginsberg JP; Neglia JP; Sklar CA; Castellino SM; Dreyer ZE; Hudson MM; Robison LL; Blanco JG; Relling MV; Burridge P; Bhatia S
    Cancer; 2020 Sep; 126(17):4051-4058. PubMed ID: 32413235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute cardiac functional and morphological changes after Anthracycline infusions in children.
    Ganame J; Claus P; Eyskens B; Uyttebroeck A; Renard M; D'hooge J; Gewillig M; Bijnens B; Sutherland GR; Mertens L
    Am J Cardiol; 2007 Apr; 99(7):974-7. PubMed ID: 17398195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dobutamine stress echocardiography in the evaluation of late anthracycline cardiotoxicity in childhood cancer survivors.
    De Wolf D; Suys B; Maurus R; Benoit Y; Verhaaren H; Matthijs D; Otten J
    Pediatr Res; 1996 Mar; 39(3):504-12. PubMed ID: 8929873
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.
    Mercuro G; Cadeddu C; Piras A; Dessì M; Madeddu C; Deidda M; Serpe R; Massa E; Mantovani G
    Oncologist; 2007 Sep; 12(9):1124-33. PubMed ID: 17914082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased arterial stiffness in children treated with anthracyclines for malignant disease.
    Herceg-Cavrak V; Ahel V; Batinica M; Matec L; Kardos D
    Coll Antropol; 2011 Jun; 35(2):389-95. PubMed ID: 21755708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myocardial Deformation Imaging by Speckle-Tracking Echocardiography for Assessment of Cardiotoxicity in Children during and after Chemotherapy: A Systematic Review and Meta-Analysis.
    Li VW; So EK; Wong WH; Cheung YF
    J Am Soc Echocardiogr; 2022 Jun; 35(6):629-656. PubMed ID: 35149208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Early detection of anthracyclines cardiotoxicity by tissue Doppler echocardiography about 45 cases at Abidjan institute of cardiology].
    Pio M; Adoubi K; Adoh A; Didi-Kouko C; Anzouan-Kacou JB; Tegnan A; Adoubi I
    Ann Cardiol Angeiol (Paris); 2013 Feb; 62(1):28-33. PubMed ID: 22513244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of cardiac reserved function by high-dose dobutamine-stress echocardiography in asymptomatic anthracycline-treated survivors of childhood cancer.
    Hamada H; Ohkubo T; Maeda M; Ogawa S
    Pediatr Int; 2006 Jun; 48(3):313-20. PubMed ID: 16732801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subclinical cardiac dysfunction and exercise performance in childhood cancer survivors.
    De Caro E; Smeraldi A; Trocchio G; Calevo M; Hanau G; Pongiglione G
    Pediatr Blood Cancer; 2011 Jan; 56(1):122-6. PubMed ID: 21058389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac changes associated with growth hormone therapy among children treated with anthracyclines.
    Lipshultz SE; Vlach SA; Lipsitz SR; Sallan SE; Schwartz ML; Colan SD
    Pediatrics; 2005 Jun; 115(6):1613-22. PubMed ID: 15930224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Valvular abnormalities detected by echocardiography in 5-year survivors of childhood cancer: a long-term follow-up study.
    van der Pal HJ; van Dijk IW; Geskus RB; Kok WE; Koolen M; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC; van Dalen EC
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):213-22. PubMed ID: 25442333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regional cardiac wall motion abnormalities during and shortly after anthracyclines therapy.
    Kapusta L; Groot-Loonen J; Thijssen JM; DeGraaf R; Daniëls O
    Med Pediatr Oncol; 2003 Nov; 41(5):426-35. PubMed ID: 14515381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.